Clinical Due Diligence
Clinical Due Diligence has an equal level of importance as financial and legal due diligence for investment decisions.
Aepodia provides Clinical Due Diligence (from preclinical pharmacology data up to Phase 2 clinical data) to evaluate:
- The pertinence of available preclinical and clinical data
- The interpretation of available compound information
- The level of quality and regulatory compliance
- The robustness of the IP
This evaluation is summarized in a technical report and a SWOT analysis.
Our network of consultants and experts in various areas (toxicology, pre-clinical drug metabolism, chemistry, GLP and GMP) ensure complete and efficient due diligence execution.
